FibroBiologics Inc. Common Stock (FBLG) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    FibroBiologics Inc. Commo...

    NASDAQ: FBLG · Real-Time Price · USD
    0.55
    0.00 (0.15%)
    At close: Oct 06, 2025, 3:25 PM

    FibroBiologics Common Stock Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -11.16M -16.48M -5.12M -1.58M
    Depreciation & Amortization
    		 573K 437K 94K n/a
    Stock-Based Compensation
    		 2.22M 1.76M 265K n/a
    Other Working Capital
    		 -694K 352K 307K 172K
    Other Non-Cash Items
    		 -4.09M 7.39M 842K n/a
    Deferred Income Tax
    		 n/a n/a n/a n/a
    Change in Working Capital
    		 559K 493K 307K 172K
    Operating Cash Flow
    		 -11.9M -6.4M -4.07M -1.41M
    Capital Expenditures
    		 -184K -495K n/a n/a
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a
    Other Investing Acitivies
    		 n/a n/a n/a n/a
    Investing Cash Flow
    		 -184K -495K n/a n/a
    Debt Repayment
    		 9.4M n/a 3.77M 1.52M
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 n/a -2.35M 2.15M 292K
    Financial Cash Flow
    		 16.91M 13.79M 5.92M 1.82M
    Net Cash Flow
    		 4.82M 6.9M 1.86M 407K
    Free Cash Flow
    		 -12.09M -6.9M -4.07M -1.41M

    Add to Watchlist